메뉴 건너뛰기




Volumn 65, Issue 1, 2009, Pages 74-79

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer

Author keywords

Cisplatin; Non small cell lung cancer; Radiation; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

EID: 67349205897     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.10.019     Document Type: Article
Times cited : (15)

References (29)
  • 1
    • 0029966671 scopus 로고    scopus 로고
    • Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06
    • Lee J.S., Scott C., Komaki R., Fossella F.V., Dundas G.S., McDonald S., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 14 (1996) 1055-1064
    • (1996) J Clin Oncol , vol.14 , pp. 1055-1064
    • Lee, J.S.1    Scott, C.2    Komaki, R.3    Fossella, F.V.4    Dundas, G.S.5    McDonald, S.6
  • 2
    • 0029936922 scopus 로고    scopus 로고
    • Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study
    • Reboul F., Brewer Y., Vincent P., Chauvet B., Faure C.F., and Taulelle M. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study. Int J Radiat Oncol Biol Phys 35 (1996) 343-350
    • (1996) Int J Radiat Oncol Biol Phys , vol.35 , pp. 343-350
    • Reboul, F.1    Brewer, Y.2    Vincent, P.3    Chauvet, B.4    Faure, C.F.5    Taulelle, M.6
  • 3
    • 0033989705 scopus 로고    scopus 로고
    • A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
    • Segawa Y., Ueoka H., Kiura K., Kamei H., Tabata M., Sakae K., et al. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Br J Cancer 82 (2000) 104-111
    • (2000) Br J Cancer , vol.82 , pp. 104-111
    • Segawa, Y.1    Ueoka, H.2    Kiura, K.3    Kamei, H.4    Tabata, M.5    Sakae, K.6
  • 4
    • 0029835349 scopus 로고    scopus 로고
    • Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators
    • Shirasaka T., Shimamato Y., Ohshimo H., Yamaguchi M., Kato T., Yonekura K., et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7 (1996) 548-557
    • (1996) Anticancer Drugs , vol.7 , pp. 548-557
    • Shirasaka, T.1    Shimamato, Y.2    Ohshimo, H.3    Yamaguchi, M.4    Kato, T.5    Yonekura, K.6
  • 5
    • 33646469073 scopus 로고    scopus 로고
    • Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil
    • Yamashita T., Ueda Y., Fuji N., Itoh T., Kurioka H., Shirasaka T., et al. Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil. Cancer Chemother Pharmacol 58 (2006) 183-188
    • (2006) Cancer Chemother Pharmacol , vol.58 , pp. 183-188
    • Yamashita, T.1    Ueda, Y.2    Fuji, N.3    Itoh, T.4    Kurioka, H.5    Shirasaka, T.6
  • 6
    • 0035964611 scopus 로고    scopus 로고
    • Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
    • Kawahara M., Furuse K., Segawa Y., Yoshimori K., Matsui K., Kudoh S., et al. Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer 85 (2001) 939-943
    • (2001) Br J Cancer , vol.85 , pp. 939-943
    • Kawahara, M.1    Furuse, K.2    Segawa, Y.3    Yoshimori, K.4    Matsui, K.5    Kudoh, S.6
  • 7
    • 9744222663 scopus 로고    scopus 로고
    • S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial
    • Ichinose Y., Yoshimori K., Sakai H., Nakai Y., Sugiura T., Kawahara M., et al. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial. Clin Cancer Res 10 (2004) 7860-7864
    • (2004) Clin Cancer Res , vol.10 , pp. 7860-7864
    • Ichinose, Y.1    Yoshimori, K.2    Sakai, H.3    Nakai, Y.4    Sugiura, T.5    Kawahara, M.6
  • 8
    • 0027468646 scopus 로고
    • Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines
    • Tsai C.M., Hsiao S.H., Frey C.M., Chang K.T., Perng R.P., Gazdar A.F., et al. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines. Cancer Res 53 (1993) 1079-1084
    • (1993) Cancer Res , vol.53 , pp. 1079-1084
    • Tsai, C.M.1    Hsiao, S.H.2    Frey, C.M.3    Chang, K.T.4    Perng, R.P.5    Gazdar, A.F.6
  • 9
    • 18544373369 scopus 로고    scopus 로고
    • Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining
    • Boeckman H.J., Trego K.S., and Turchi J.J. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining. Mol Cancer Res 3 (2005) 277-285
    • (2005) Mol Cancer Res , vol.3 , pp. 277-285
    • Boeckman, H.J.1    Trego, K.S.2    Turchi, J.J.3
  • 10
    • 0025234015 scopus 로고
    • Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors
    • Vokes E.E., and Weichselbaum R.R. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8 (1990) 911-934
    • (1990) J Clin Oncol , vol.8 , pp. 911-934
    • Vokes, E.E.1    Weichselbaum, R.R.2
  • 11
    • 0036172691 scopus 로고    scopus 로고
    • The combined use of radiotherapy and chemotherapy in the treatment of solid tumours
    • Bartelink H., Schellens J.H., and Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 38 (2002) 216-222
    • (2002) Eur J Cancer , vol.38 , pp. 216-222
    • Bartelink, H.1    Schellens, J.H.2    Verheij, M.3
  • 12
    • 2542506412 scopus 로고    scopus 로고
    • Combined effects of the oral fluoropyrimidine anticancer agent S-1 and radiation on human oral cancer cells
    • Harada K., Kawaguchi S., Supriatno, Onoue T., Yoshida H., and Sato M. Combined effects of the oral fluoropyrimidine anticancer agent S-1 and radiation on human oral cancer cells. Oral Oncol 40 (2004) 713-719
    • (2004) Oral Oncol , vol.40 , pp. 713-719
    • Harada, K.1    Kawaguchi, S.2    Supriatno3    Onoue, T.4    Yoshida, H.5    Sato, M.6
  • 13
    • 33749169384 scopus 로고    scopus 로고
    • S-1 an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU
    • Nakata E., Fukushima M., Takai Y., Nemoto K., Ogawa Y., Nomiya T., et al. S-1 an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. Oncol Rep 16 (2006) 465-471
    • (2006) Oncol Rep , vol.16 , pp. 465-471
    • Nakata, E.1    Fukushima, M.2    Takai, Y.3    Nemoto, K.4    Ogawa, Y.5    Nomiya, T.6
  • 14
    • 33845633056 scopus 로고    scopus 로고
    • Combined therapy with radiation and S-1, an oral new 5FU prodrug, is markedly effective against non-small cell lung cancer xenografts in mice
    • Paris
    • Fukushima M., Ohshimo H., and Taguchi T. Combined therapy with radiation and S-1, an oral new 5FU prodrug, is markedly effective against non-small cell lung cancer xenografts in mice. ECCO 13-The European Cancer Conference, vol. 3. Paris (2005) 343
    • (2005) ECCO 13-The European Cancer Conference, vol. 3 , pp. 343
    • Fukushima, M.1    Ohshimo, H.2    Taguchi, T.3
  • 15
    • 27144441763 scopus 로고    scopus 로고
    • Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer
    • Tsukuda M., Kida A., Fujii M., Kono N., Yoshihara T., Hasegawa Y., et al. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer 93 (2005) 884-889
    • (2005) Br J Cancer , vol.93 , pp. 884-889
    • Tsukuda, M.1    Kida, A.2    Fujii, M.3    Kono, N.4    Yoshihara, T.5    Hasegawa, Y.6
  • 16
    • 67349113384 scopus 로고    scopus 로고
    • Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN)
    • Tahara M, Minami H, Mukai H, Kawada K, Kawashima M, Ogino T, Yamazaki M, et al. Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN). Proceeding of ASCO meeting, vol. 23, 2005: 5575.
    • (2005) Proceeding of ASCO meeting , vol.23 , pp. 5575
    • Tahara, M.1    Minami, H.2    Mukai, H.3    Kawada, K.4    Kawashima, M.5    Ogino, T.6    Yamazaki, M.7
  • 17
    • 0141841805 scopus 로고    scopus 로고
    • Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
    • Kiura K., Ueoka H., Segawa Y., Tabata M., Kamei H., Takigawa N., et al. Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer. Br J Cancer 89 (2003) 795-802
    • (2003) Br J Cancer , vol.89 , pp. 795-802
    • Kiura, K.1    Ueoka, H.2    Segawa, Y.3    Tabata, M.4    Kamei, H.5    Takigawa, N.6
  • 18
    • 0030912190 scopus 로고    scopus 로고
    • Revisions in the international system for staging lung cancer
    • Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
    • (1997) Chest , vol.111 , pp. 1710-1717
    • Mountain, C.F.1
  • 19
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5    Rubinstein, L.6
  • 20
    • 0027493511 scopus 로고
    • Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study
    • Adelstein D.J., Kalish L.A., Adams G.L., Wagner Jr. H., Oken M.M., Remick S.C., et al. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 11 (1993) 2136-2142
    • (1993) J Clin Oncol , vol.11 , pp. 2136-2142
    • Adelstein, D.J.1    Kalish, L.A.2    Adams, G.L.3    Wagner Jr., H.4    Oken, M.M.5    Remick, S.C.6
  • 21
    • 0030792647 scopus 로고    scopus 로고
    • Radiation Therapy With 5-fluorouracil in Head and Neck Cancer
    • Fu K.K. Radiation Therapy With 5-fluorouracil in Head and Neck Cancer. Semin Radiat Oncol 7 (1997) 274-282
    • (1997) Semin Radiat Oncol , vol.7 , pp. 274-282
    • Fu, K.K.1
  • 22
    • 0027285520 scopus 로고
    • Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo
    • Shirasaka T., Shimamoto Y., Ohshimo H., Saito H., and Fukushima M. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32 (1993) 167-172
    • (1993) Cancer Chemother Pharmacol , vol.32 , pp. 167-172
    • Shirasaka, T.1    Shimamoto, Y.2    Ohshimo, H.3    Saito, H.4    Fukushima, M.5
  • 23
    • 1542269125 scopus 로고    scopus 로고
    • The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors
    • Schoffski P. The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs 15 (2004) 85-106
    • (2004) Anticancer Drugs , vol.15 , pp. 85-106
    • Schoffski, P.1
  • 24
    • 4444293137 scopus 로고    scopus 로고
    • Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
    • Zatloukal P., Petruzelka L., Zemanova M., Havel L., Janku F., Judas L., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 (2004) 87-98
    • (2004) Lung Cancer , vol.46 , pp. 87-98
    • Zatloukal, P.1    Petruzelka, L.2    Zemanova, M.3    Havel, L.4    Janku, F.5    Judas, L.6
  • 25
    • 24944542868 scopus 로고    scopus 로고
    • Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol
    • Belani C.P., Choy H., Bonomi P., Scott C., Travis P., Haluschak J., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
    • (2005) J Clin Oncol , vol.23 , pp. 5883-5891
    • Belani, C.P.1    Choy, H.2    Bonomi, P.3    Scott, C.4    Travis, P.5    Haluschak, J.6
  • 26
    • 34248651350 scopus 로고    scopus 로고
    • Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B
    • Vokes E.E., Herndon II J.E., Kelley M.J., Cicchetti M.G., Ramnath N., Neill H., et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25 (2007) 1698-1704
    • (2007) J Clin Oncol , vol.25 , pp. 1698-1704
    • Vokes, E.E.1    Herndon II, J.E.2    Kelley, M.J.3    Cicchetti, M.G.4    Ramnath, N.5    Neill, H.6
  • 27
    • 0032858243 scopus 로고    scopus 로고
    • Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
    • Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
    • (1999) J Clin Oncol , vol.17 , pp. 2692-2699
    • Furuse, K.1    Fukuoka, M.2    Kawahara, M.3    Nishikawa, H.4    Takada, Y.5    Kudoh, S.6
  • 28
    • 0032840324 scopus 로고    scopus 로고
    • Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
    • Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
    • (1999) Int J Radiat Oncol Biol Phys , vol.45 , pp. 323-329
    • Graham, M.V.1    Purdy, J.A.2    Emami, B.3    Harms, W.4    Bosch, W.5    Lockett, M.A.6
  • 29
    • 33750482212 scopus 로고    scopus 로고
    • Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
    • Takigawa N., Kiura K., Segawa Y., Watanabe Y., Kamei H., Moritaka T., et al. Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Br J Cancer 95 (2006) 1142-1144
    • (2006) Br J Cancer , vol.95 , pp. 1142-1144
    • Takigawa, N.1    Kiura, K.2    Segawa, Y.3    Watanabe, Y.4    Kamei, H.5    Moritaka, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.